A Cannabis Retailer’s Guide to Reducing Shrink and Inventory Variances
Shrink is a double-edged threat for cannabis retailers – it drains profit and puts compliance at risk. In…
Resources June 26
Latest In: Ancillary
Green Life Business Group brokers the cannabis industry’s biggest deals
The best time to get into the cannabis industry is now.
Sponsored June 22
Legal cannabis industry sheds jobs for first time
Retail revenue fell to $29.1 billion – the first year-over-year drop since adult-use sales began, according to the…
News June 22
Sponsored
The Next Competitive Advantage in Medical Cannabis Is Clarity
As telehealth simplifies access where permitted, providers are discovering that the real differentiator is helping patients understand what happens before, during, and after certification.
June 30
Cannabis payments are facing a reckoning as workarounds disappear
Cannabis operators are used to payment solutions that disappear overnight. But as margins squeeze, that's a risk most…
News May 29
Vireo Growth’s latest deals see cannabis MSO expand to real estate, agribusiness
The MSO bought its New York cultivation facility from landlord Innovative Industrial Properties for $88.5 million.
News May 27
New York promises cannabis operators help to pay for track-and-trace
New York cannabis operators may be able to seek assistance in paying for seed-to-sale tracking requirements.
News May 26
Past-due cannabis invoices expose a growing credit discipline gap
Brett Gelfand created Cannabiz Credit Association help cannabis operators make better decisions on who to extend credit to.
News May 14
Big tech platforms inch closer to cannabis acceptance after rescheduling
Rescheduling may give marijuana companies more room to market themselves, but the change is unlikely to result in…
News May 11
Fuel costs and canceled orders: How the US-led war on Iran is hurting cannabis
Disruptions to the global supply chain stemming from the U.S.-led war on Iran are causing significant headaches to…
News May 3
Is federal marijuana rescheduling good for Big Pharma?
With rescheduling, investors and financial institutions that worried about the stigma surrounding marijuana are taking another look.
News April 30
Latest Sponsored
